medline.ch Dermatologie Psoriasis

	Safety and Efficacy of the Oral IL-23 Receptor Antagonist Icotrokinra for Plaque Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Cutan Med Surg Abdeldayem MR, Elsherbeeny A. PMID: 41679329 [PubMed - as supplied by publisher]
	Real-World Predictors of Relapse-Free Duration After Narrowband UVB in Pediatric Psoriasis: A Multicenter Study. Photodermatol Photoimmunol Photomed Solak B, Engin B, Güngör Z, Tolun ÖF, Türko, Ba, Canat HD, Çetinarslan T, Ermertcan AT, Gezmen S, Zorlu Ö, Albayrak H, Caf N, Türsen Ü. PMID: 41678732 [PubMed - indexed for MEDLINE]
	Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study. J Eur Acad Dermatol Venereol Cai L, Man XY, Wang J, Wei A, Chen Y, Deherder D, Gao J, Hoepken B, Sun W, Lei T, Zhang J, BE SHINING Study Group. PMID: 41678327 [PubMed - as supplied by publisher]
	A 76-week real-world multidimensional analysis of guselkumab in moderate to severe plaque psoriasis: a retrospective cohort study based on Chinese clinical practice standards. Front Immunol Hu R, Li Q, Liu X, Hu Y, Pan Y, Liu C, Lu P, Chen X, Xiong J, Zhang J, Huang K. PMID: 41676155 [PubMed - indexed for MEDLINE]
	Identification of UBE2T as a novel diagnostic biomarker of psoriasis and proliferating UBE2T+ Keratinocyte in psoriasis. J Transl Med Chen J, Peng L, Yang T, Chen S, Tang Y, Li D, Yuan X. PMID: 41673685 [PubMed - as supplied by publisher]
	Phase 1 study of balinatunfib, an oral inhibitor of TNFR1 signal in mild-to-moderate psoriasis. J Eur Acad Dermatol Venereol Nassr N, Chow OA, Nguyen MA, Perrin L, Schumacher F, Wagner FD, Dreis C, Lahmar A, Kohlmann M, Wiekowski M, Matos TR. PMID: 41671079 [PubMed - as supplied by publisher]
	Efficacy and Safety of Guselkumab in Participants with Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week-24 Results of the Phase 3, Randomized, Placebo-Controlled SOLSTICE Study. Arthritis Rheumatol Ogdie A, Merola JF, Mease PJ, Ritchlin CT, Scher JU, Lafferty KP, Chan D, Chakravarty SD, Langholff W, Wang Y, Shao J, Krol Y, Gottlieb AB. PMID: 41670439 [PubMed - as supplied by publisher]
	Efficacy of Flaxseed Oil in Treating Mild to Moderate Psoriasis Vulgaris Compared with Topical Betamethasone: A Randomized, Double-Blind, Clinical Trial. Adv Biomed Res Mohammadian Rasanan F, Ghobadi A, Mohammadi Kenari H, Ghassemi M, Ghods R, Taghavi Shirazi M. PMID: 41669307 [PubMed]
	Patient Satisfaction Using Guselkumab Self-administered Using the One-Press Device for Treatment of Moderate-to-Severe Psoriasis: Results from a National, Prospective, Real-World Study in Portugal (CERES Study). Dermatol Ther (Heidelb) Torres T, Sousa JT, Antunes J, Mendes-Bastos P, Brasileiro A, Neto V, Henrique M, Pimenta R, Magina S, Lourenço D, Mota F. PMID: 41665798 [PubMed - as supplied by publisher]
	Predictors of Efficacy Maintenance After Vunakizumab Discontinuation in Patients With Moderate-to-Severe Plaque Psoriasis: A Post Hoc Analysis of a Randomized Controlled Trial. Int J Dermatol Yu X, Li Y, Qiu X, Jin X, Yuan L, Wang X. PMID: 41665599 [PubMed - as supplied by publisher]
	Economic Burden of Generalized Pustular Psoriasis: A Population-based Register Study in Finland. Acta Derm Venereol Teitsma X, Huilaja L, Koivusalo M, Mehtälä J, Vesikansa A, Kappelhoff B, Grönman M, Kaukua J, Nuutinen P, Pasternack R. PMID: 41665271 [PubMed - indexed for MEDLINE]
	Analytical study on metabolic syndrome and psoriasis severity: A cross sectional study. Bioinformation Navaneeta Krishnan AV, Lingaraj AG, Kammoun A, Mareboina SK, John SE, Chacko J, Pullithodika MN. PMID: 41657612 [PubMed]
	Successful Long-Term Management of Psoriatic Arthritis With Apremilast Following Multiple Myeloma Diagnosis During Etanercept Therapy: A 20-Month Follow-up. Ann Pharmacother Nigro A. PMID: 41656754 [PubMed - as supplied by publisher]
	Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Psoriasis and Comorbid Type 2 Diabetes: A Population-based Target Trial Emulation. J Am Acad Dermatol Cheng D, Ji H, Theodosakis N, Noe MH, Chen ST, Sheng-Kai Ma K. PMID: 41655841 [PubMed - as supplied by publisher]
	Targeting the PTCHD1-hippo axis by rhPTH(1-34) restores contact inhibition and suppresses hyperproliferation in psoriatic keratinocytes. Eur J Pharmacol Guo J, Zhao W, Feng L, Bu X. PMID: 41651334 [PubMed - as supplied by publisher]
	Causal relationships between psoriasis and coronary artery disease: A two-sample Mendelian randomization study. Medicine (Baltimore) Xu Y, Zhao J. PMID: 41650090 [PubMed - indexed for MEDLINE]
	Uncovering metabolite-immune interactions in the pathogenesis of psoriatic arthritis: A 2-sample Mendelian randomization study. Medicine (Baltimore) Chen S, Gan Y, Jin Y, Dong X, Wang F, Wu Z, Liu Z, Zhang Z. PMID: 41650029 [PubMed - indexed for MEDLINE]
	Comment on: FIB-4 as an effective screening tool in psoriatic arthritis patients at high-risk for liver disease: a cross-sectional study using FibroScan: Reply. Rheumatology (Oxford) Meridor K, Harrison SR, Parker R, Chimakurthi R, Laws PM, McGonagle D, Barr A, Vandevelde CY, Marzo-Ortega H, Freeston JE. PMID: 41649459 [PubMed - as supplied by publisher]
	Emerging Targets in Psoriatic Arthritis: Dual IL-17A/F and Selective TYK2 Inhibition in a Clinical Perspective. Mediterr J Rheumatol Dimopoulou V, Nitsa M, Koutsianas C. PMID: 41648065 [PubMed]
	Beyond Clinical Trials: Experience with Bimekizumab in 3 Challenging Cases of Psoriatic Arthritis. Mediterr J Rheumatol Papadimitriou E, Katsigianni I, Papoutsaki M, Visvikis M, Dimitroulas T, Koutsianas C, Papagoras C. PMID: 41648064 [PubMed]

Artikel 1 - 20 / 27448

Seite 1 von 1373

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung